We develop insights and strategies that are designed for the unique challenges of managed-care markets, as well as the tactics and tools to ensure rapid product uptake.

Our consulting projects encompass topics across the biopharmaceutical, medical device, and diagnostic product lifecycles.

Areas of focus

We focus on strategies and tactics that address product reimbursement from third-party payors and the government.  Message development for communication with key stakeholders, assessment or development of patient access and support initiatives, tool development to remove barriers to access, and product pricing and validation are related services we provide.

Our Compliance Expertise Balances Regulatory, Legal, and Commercial Considerations to Ensure that Programs are Within the Regulatory and Legal Bounds Required by Today's Commercial Environment

1798 Consultants integrates compliance, reimbursement, and commercialization expertise through our diverse and strategically designed project teams.  Our goal: maximize opportunity while complying with existing regulations.

A conservative approach to compliance may leave opportunity on the table, while an aggressive approach may place the company in jeopardy.

Given the increased scrutiny of the entire healthcare industry by the Office of the Inspector General (OIG), it is imperative for manufacturers to be cognizant of the importance of developing only those impactful business strategies that avoid the damage that can be caused by non-compliant actions.

Our expert approach to compliance includes evaluating, among others:

• Safe Harbors
• Anti-Kickback Provisions 
• False Claims Act
• OIG Compliance Program
• PhRMA and AdvaMed Codes
• ACCME Standards 

We can also help you streamline mandated data reporting

To learn more about appropriate Compliance design and integration with biopharmaceutical strategy, please visit the 1798 Compliance website.

Analytic Services to Support Client Strategies and Operations
 
Complementary to our reimbursement, compliance, and commercialization consulting services, we also offer quantitative applied analytical solutions through performance based analysis measured against your company metrics. 

Our services include:

• Measurement definition - To assure that each study is appropriate to our client's needs
• Quantitative analysis - For product and business development, as well as evaluations of healthcare programs
• Customized Reports - Relevant findings and recommended solutions

Customized Offerings for Unique Client Requirements

1798 Consultants develops and delivers customized reimbursement training programs for biopharmaceutical, medical device, and diagnostic companies.

Our training programs can be targeted to company executives, field sales/managed markets forces, or internal company trainers.

We aim for training that delivers immediate impact.

An expert step-by-step approach:

• Product Overview - Define the product in terms of medical and/or pharmacy claims. Review brand strategies to ensure appropriate patient access.
• Payor Mix - Develop an outline based on the current and expected payor mix, along with the sites of service and channel requirements.
• Coverage - Utilize or develop a managed markets dashboard for the product and its competitors, so we can train against real-world, plan-specific information.
• Application - Devise scenarios to help the team refine the sales message and/or probe appropriately for additional intelligence.
• Measurement - Implement measurement and improvement processes.

Competitive intelligence has been defined to be the identification, collection, analysis, and distribution of intelligence about products, customers, competitors and any aspect of the environment needed to make strategic decisions for an organization.
 
1798 Consultants delivers competitive advantage to our clients through cross-functional insight and ethical application of the insights and intelligence gathered across our myriad engagements.  Our customized competitive intelligence offerings are designed with client needs in mind to deliver actionable insights and deliverables that facilitate informed decision-making.
 
Competitive intelligence engagements include:

• Environmental Scan - Informed by primary and secondary research, emphasis is placed on regulatory forces, global markets, direct competitors, payors, and disruptive technologies to anticipate issues for proactive management and decision making
• Pipeline Analysis - Review of potential competitors by modality, target, or therapeutic area identifies both opportunities and threats which then may inform diverse business needs such as clinical trials, publication schedules, or launch plans